Johan Kördel appears on DI TV stating that “the time to invest in Biotech is now”!

Sound Bioventures is a venture capital fund that invests in private clinical stage therapeutics companies. The managing partner Johan Kördel was invited to the Swedish financial media channel Dagens Industri (DI) to talk about the great opportunity to invest in Biotech right now: “The innovation rate keeps accelerating research and there are exciting new things to invest in at the same time as the valuations are suppressed. If you have a longer investment horizon than a quarter, this is the sector you should be in

The interview is in Swedish. DiTV is a Swedish television channel owned by the financial newspaper Dagens Industri.

Subscribe

* indicates required

ARTHEx Biotech Receives IND Clearance from FDA to Initiate the Phase I-IIa ArthemiR™ Trial of ATX-01 for Myotonic Dystrophy Type 1 (DM1)

-ATX-01 is the industry’s first microRNA therapeutic to be evaluated for DM1 and the first program from ARTHEX’s pipeline to enter the clinic – -First patient expected to be enrolled in Q2 2024- Valencia, Spain, February 28th, 2024 – ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the m ...

Subscribe

* indicates required